Y-MABS THERAPEUTICS INC. - COMMON STOCK

Y-mAbs Announces Data to be Presented at 2021 ASCO Annual Meeting

29 أبريل 2021 08:00:02 بحسب Nasdaq GlobeNewswire

Y-mAbs Submits Omburtamab Marketing Authorization Application to the European Medicines Agency

27 أبريل 2021 15:01:00 بحسب Nasdaq GlobeNewswire

Y-mAbs Provides Regulatory Update on Omburtamab   

20 أبريل 2021 08:00:01 بحسب Nasdaq GlobeNewswire

Y-mAbs Announces GPA33-SADA Data Presented at AACR

12 أبريل 2021 08:00:00 بحسب Nasdaq GlobeNewswire

Y-mAbs Announces 2020 Financial Results and Recent Corporate Developments

25 فبراير 2021 15:01:00 بحسب Nasdaq GlobeNewswire

Y-mAbs Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

22 فبراير 2021 15:01:00 بحسب Nasdaq GlobeNewswire

Y-mAbs to Announce 2020 Financial and Operating Results on February 25, 2021

19 فبراير 2021 08:00:00 بحسب Nasdaq GlobeNewswire

Y-mAbs Announces Pricing of Public Offering of Common Stock

17 فبراير 2021 18:14:43 بحسب Nasdaq GlobeNewswire

Y-mAbs Announces Proposed Public Offering of Common Stock

16 فبراير 2021 15:01:00 بحسب Nasdaq GlobeNewswire

Y-mAbs Therapeutics to Present At 39th Annual J.P. Morgan Healthcare Conference

06 يناير 2021 08:00:00 بحسب Nasdaq GlobeNewswire